Diagnosis of quinolone-resistant Coxiella burnetii strains by PCR-RFLP

Journal of Clinical Laboratory Analysis

Volumn 14, Issue 2, 2000, Pages 59-63

  Spyridaki, Ioanna ^a,b   Psaroulaki, Anna ^a   Aransay, Ana ^a   Scoulica, Efstathia ^a   Tselentis, Yannis ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

Coxiella burnetii; Diagnosis; gyrA; PCR RFLP; Quinolones; Resistant

Indexed keywords

CIPROFLOXACIN; PEFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; COXIELLA BURNETII; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STRAIN DIFFERENCE;

AMINO ACID SEQUENCE; BASE SEQUENCE; COXIELLA BURNETII; DEOXYRIBONUCLEASES, TYPE II SITE-SPECIFIC; DNA GYRASE; DNA TOPOISOMERASES, TYPE II; DNA, BACTERIAL; DRUG RESISTANCE, MICROBIAL; GREECE; HUMANS; MOLECULAR SEQUENCE DATA; PEFLOXACIN; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; Q FEVER; QUINOLONES; SEQUENCE ANALYSIS, DNA;

BACTERIA (MICROORGANISMS); COXIELLA BURNETII;

EID: 0034052782     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(2000)14:2<59::AID-JCLA4>3.0.CO;2-P     Document Type: Article

References (26)

1. Aitken ID, Bogel K, Cracea E. et al. Q fever in Europe: current aspects of etiology, epidemiology, human infection diagnosis and therapy. Infection 1987;15:323-327.
2. Raoult D, Marrie T. Q fever. Clin Infect Dis 1995;20:489-496.
3. Raoult D. 1993. Treatment of Q fever. Antimicrob Agents Chemother 1995;37:1733-1736.
4. Bourignon GJ, Levitt M, Sternglantz R. Studies on the mechanism of action of nalidixic acid. Antimicrob Agents Chemother 1973;4: 479-486.
5. Goss WA, Deitz WH, Cook TM. Mechanism of action of nalidixic acid on Escherichia coli. Inhibition of DNA synthesis. J Bacteriol 1965;89:1068-1074.
6. Charvalos E, Peteinaki E, Spyridaki I, Manetas S, Tselentis Y. Detection of ciprofloxacin resistance mutations in Campylobacter jejuni gyrA by nonradioisotopic single-strand conformation polymorphism and direct DNA sequencing. J Clin Lab Anal 1996;10:129-133.
7. Charvalos E, Tselentis Y, Hamzehpour NM, KoehlerT, Pechere JC. Evidence for an efflux pump in multidrug resistant Campylobacter jejuni. Antimicrob Agents Chemother 1995;39:2019-2022.
8. Ferrero L, Cameron B, Manse B, et al. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones. Mol Microbiol 1994;13:641-653.
9. Pan XS, Ambler J, Mehtar S, Fisher LM. Involvement of topoisomerase IV and DNA gyrase as ciprofloxacin targets in Streptococcus pneumoniae. Antimicrob Agents Chemother 1996;40:2321-2326.
10. Tankovic J, Perichon B, Duval J, Courvalin P. Contribution of mutations in gyrA and parC genes to fluoroquinolone resistance of mutants of Streptococcus pneumoniae obtained in vivo and in vitro. Antimicrob Agents Chemother 1996;40:2505-2510.
11. Bebear CM, Charron A, Bove JM, Bebear C, Renaudin J. Cloning and nucleotide sequences of the topoisomerase IV parC and parE genes of Mycoplasma hominis. Antimicrob Agents Chemother 1998;42:2024-2031.
12. Khodursky AB, Zechiedrich EL, Cozzarelli NR. Topoisomerase IV is a target of quinolones in Escherichia coli. Proc Natl Acad Sci U S A 1995;92:11801-11805.
13. Deguchi T, Yasuda M, Nakano M, et al. Quinolone-resistant Neisseria gonorrhoeae: correlation of alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV with antimicrobial susceptibility profiles. Antimicrob Agents Chemother 1996;40:1020-1023.
14. Deguchi T, Fukuoka A, Yasuda M, et al. Alterations in the GyrA subunit of DNA gyrase and the ParC subunit of topoisomerase IV in quinolone-resistant clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1997;41:699-701.
15. Kocagoz T, Hackbarth CJ, Unsal I, Rosenberg EY, Nikaido H, Chambers HF. Gyrase mutations in laboratory-selected, fluoroquinolone-resistant mutants of mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother 1996;40:1768-1774.
16. Musso D, Drancourt M, Osscini S, Raoult D. Sequence of quinolone resistance-determining region of gyrA gene for clinical isolates and for an in vitro-selected quinilone-resistant strain of Coxiella burnetii. Antimicrob Agents Chemother 1996;40:870-873.
17. Goswitz JJ, Willard KE, Fasching CE, Peterson LR. Detection of gyrA gene mutations associated with ciprofloxacin resistance in methicillin-resistant Staphylococcus aureus: Analysis by polymerase chain reaction and direct DNA sequencing. Antimicrob Agents Chemother 1992;36:1166-1169.
18. Fasching CE, Tenover FC, Slama TG, et al. gyrA mutations in ciprofloxacin-resistant, methicillin resistant Staphylococcus aureus from Indiana, Minnesota and Tennessee. J Infect Dis 1991;164:976-979.
19. Spyridaki I, Gikas A, Kofteridis D, Psaroulaki A, Tselentis Y. Q fever in the greek island of Crete: detection, isolation, and molecular identification of eight strains of Coxiella burnetii from clinical samples. J Clin Microbiol 1998;36:2063-2067.
20. Gimenez DF. Staining rickettsiae in yolk-sac cultures. Stain Technol 1964;39:135-140.
21. Gikas A, Spyridaki I, Psaroulaki A, Kofterithis D, Tselentis Y. In vitro susceptibility of Coxiella burnetii to trovafloxacin in comparison with susceptibilities to pefloxacin, ciprofloxacin, ofloxacin, doxycycline, and clarithromycin. Antimicrob Agents Chemother 1998;42:2747-2748.
22. Stein A, Raoult D. Phenotypic and genotypic heterogeneity of 8 new human Coxiella burnetii isolates. Acta Virol 1992;36:7-12.
23. Raoult D, Vestris G, Enea M. Isolation of 16 strains of Coxiella burnetii from patients by using a sensitive centrifugation cell culture system and establishment of the strains in HEL cells. J Clin Microbiol 1990;28:2482-2484.
24. Streedharan S, Peterson IR, Fisher LM. DNA gyrase gyrA mutations in ciprofloxacin resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. J Bacteriiol 1990;172:7260-7262.
25. Rahman M, Mauff G, Levy J, et al. Detection of 4-quinolone resistance mutations in gyrA gene of Shigella dysenteriae type I hy PCR. Antimicrob Agents Chemother 1994;38:2488-2491.
26. Dimri GP, Das HK. Cloning and sequence analysis of a gyrA gene of Klebsiella pneumoniae. Nucleic Acids Res 1990;18:151-156.